)
Abeona Therapeutics (ABEO) investor relations material
Abeona Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 12, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 11, 2026.
Voting matters and shareholder proposals
Election of three Class 1 Directors for a three-year term: Michael Amoroso, Keith A. Goldan, and Bernhardt G. Zeiher, M.D.
Advisory vote to approve named executive officer compensation.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to increase shares reserved under the 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.
Amendment to Restated Certificate of Incorporation to remove advance notice provision for director nominations.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and governance amendments.
- Board recommends approval of all five key proposals at the 2026 annual meeting.ABEO
Proxy filing27 Apr 2026 - Board recommends approval of all five key proposals at the 2026 annual meeting.ABEO
Proxy filing17 Apr 2026 - FDA approval, first treatment, and $71.2M net income highlight a pivotal 2025.ABEO
Q4 202517 Mar 2026 - Launch momentum accelerates as manufacturing scales and patient demand rises across expanding centers.ABEO
Leerink Global Healthcare Conference 202610 Mar 2026 - ZEVASKYN launch accelerates with robust demand, expanding capacity, and clear path to profitability.ABEO
Jefferies Global Healthcare Conference 20253 Feb 2026 - Durable cell therapy for RDEB nears BLA resubmission, with strong efficacy and commercial readiness.ABEO
Stifel Virtual Cell Therapy Forum3 Feb 2026 - pz-cel targets durable wound closure in RDEB, with FDA resubmission and launch preparations underway.ABEO
Jefferies Global Healthcare Conference1 Feb 2026 - Q2 net income reached $7.4M; pz-cel BLA resubmission and launch prep on track for H2 2024.ABEO
Q2 20241 Feb 2026 - Pz-cel delivers long-lasting wound healing for severe EB, with strong clinical and payer support.ABEO
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
Next Abeona Therapeutics earnings date
Next Abeona Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)